Rafael J Ramirez1, Yoshio Takemoto1, Raphaël P Martins1, David Filgueiras-Rama1,2,3, Steven R Ennis1, Sergey Mironov1, Sandesh Bhushal4, Makarand Deo4, Sridharan Rajamani5,6, Omer Berenfeld1, Luiz Belardinelli5, José Jalife1,2,3, Sandeep V Pandit1. 1. Center for Arrhythmia Research, Department of Internal Medicine-Cardiology, University of Michigan, Ann Arbor (R.J.R., Y.T., R.P.M., D.F.-R., S.R.E., S.M., O.B., J.J., S.V.P.). 2. Fundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC; D.F.-R., J.J.). 3. Centros de Investigación Biomédica en Red (CIBER) for Cardiovascular Diseases, Madrid, Spain (D.F.-R., J.J.). 4. Department of Engineering, Norfolk State University, VA (S.B., M.D.). 5. Gilead Sciences, Foster City, CA (S.R., L.B.). 6. Currently: Amgen Inc, San Francisco, CA (S.R.).
Abstract
BACKGROUND: Ranolazine inhibits Na+ current (INa), but whether it can convert atrial fibrillation (AF) to sinus rhythm remains unclear. We investigated antiarrhythmic mechanisms of ranolazine in sheep models of paroxysmal (PxAF) and persistent AF (PsAF). METHODS: PxAF was maintained during acute stretch (N=8), and PsAF was induced by long-term atrial tachypacing (N=9). Isolated, Langendorff-perfused sheep hearts were optically mapped. RESULTS: In PxAF ranolazine (10 μmol/L) reduced dominant frequency from 8.3±0.4 to 6.2±0.5 Hz (P<0.01) before converting to sinus rhythm, decreased singularity point density from 0.070±0.007 to 0.039±0.005 cm-2 s-1 (P<0.001) in left atrial epicardium (LAepi), and prolonged AF cycle length (AFCL); rotor duration, tip trajectory, and variance of AFCL were unaltered. In PsAF, ranolazine reduced dominant frequency (8.3±0.5 to 6.5±0.4 Hz; P<0.01), prolonged AFCL, increased the variance of AFCL, had no effect on singularity point density (0.048±0.011 to 0.042±0.016 cm-2 s-1; P=ns) and failed to convert AF to sinus rhythm. Doubling the ranolazine concentration (20 μmol/L) or supplementing with dofetilide (1 μmol/L) failed to convert PsAF to sinus rhythm. In computer simulations of rotors, reducing INa decreased dominant frequency, increased tip meandering and produced vortex shedding on wave interaction with unexcitable regions. CONCLUSIONS: PxAF and PsAF respond differently to ranolazine. Cardioversion in the former can be attributed partly to decreased dominant frequency and singularity point density, and prolongation of AFCL. In the latter, increased dispersion of AFCL and likely vortex shedding contributes to rotor formation, compensating for any rotor loss, and may underlie the inefficacy of ranolazine to terminate PsAF.
BACKGROUND:Ranolazine inhibits Na+ current (INa), but whether it can convert atrial fibrillation (AF) to sinus rhythm remains unclear. We investigated antiarrhythmic mechanisms of ranolazine in sheep models of paroxysmal (PxAF) and persistent AF (PsAF). METHODS:PxAF was maintained during acute stretch (N=8), and PsAF was induced by long-term atrial tachypacing (N=9). Isolated, Langendorff-perfused sheep hearts were optically mapped. RESULTS: In PxAFranolazine (10 μmol/L) reduced dominant frequency from 8.3±0.4 to 6.2±0.5 Hz (P<0.01) before converting to sinus rhythm, decreased singularity point density from 0.070±0.007 to 0.039±0.005 cm-2 s-1 (P<0.001) in left atrial epicardium (LAepi), and prolonged AF cycle length (AFCL); rotor duration, tip trajectory, and variance of AFCL were unaltered. In PsAF, ranolazine reduced dominant frequency (8.3±0.5 to 6.5±0.4 Hz; P<0.01), prolonged AFCL, increased the variance of AFCL, had no effect on singularity point density (0.048±0.011 to 0.042±0.016 cm-2 s-1; P=ns) and failed to convert AF to sinus rhythm. Doubling the ranolazine concentration (20 μmol/L) or supplementing with dofetilide (1 μmol/L) failed to convert PsAF to sinus rhythm. In computer simulations of rotors, reducing INa decreased dominant frequency, increased tip meandering and produced vortex shedding on wave interaction with unexcitable regions. CONCLUSIONS:PxAF and PsAF respond differently to ranolazine. Cardioversion in the former can be attributed partly to decreased dominant frequency and singularity point density, and prolongation of AFCL. In the latter, increased dispersion of AFCL and likely vortex shedding contributes to rotor formation, compensating for any rotor loss, and may underlie the inefficacy of ranolazine to terminate PsAF.
Authors: Samuel Sossalla; Birte Kallmeyer; Stefan Wagner; Marek Mazur; Ulrike Maurer; Karl Toischer; Jan D Schmitto; Ralf Seipelt; Friedrich A Schöndube; Gerd Hasenfuss; Luiz Belardinelli; Lars S Maier Journal: J Am Coll Cardiol Date: 2010-05-25 Impact factor: 24.094
Authors: David Filgueiras-Rama; Nicholas F Price; Raphael P Martins; Masatoshi Yamazaki; Uma Mahesh R Avula; Kuljeet Kaur; Jérôme Kalifa; Steven R Ennis; Elliot Hwang; Vijay Devabhaktuni; Jose Jalife; Omer Berenfeld Journal: Circ Arrhythm Electrophysiol Date: 2012-10-10
Authors: Sandeep V Pandit; Omer Berenfeld; Justus M B Anumonwo; Roman M Zaritski; James Kneller; Stanley Nattel; José Jalife Journal: Biophys J Date: 2005-03-25 Impact factor: 4.033
Authors: Sami F Noujaim; Jeanne A Stuckey; Daniela Ponce-Balbuena; Tania Ferrer-Villada; Angelica López-Izquierdo; Sandeep V Pandit; José A Sánchez-Chapula; José Jalife Journal: Cardiovasc Res Date: 2011-01-13 Impact factor: 10.787
Authors: Andrew C Zygmunt; Vladislav V Nesterenko; Sridharan Rajamani; Dan Hu; Hector Barajas-Martinez; Luiz Belardinelli; Charles Antzelevitch Journal: Am J Physiol Heart Circ Physiol Date: 2011-08-05 Impact factor: 4.733
Authors: David Filgueiras-Rama; Raphael P Martins; Sergey Mironov; Masatoshi Yamazaki; Conrado J Calvo; Steve R Ennis; Krishna Bandaru; Sami F Noujaim; Jérôme Kalifa; Omer Berenfeld; José Jalife Journal: Circ Arrhythm Electrophysiol Date: 2012-03-30
Authors: Yoshio Takemoto; Rafael J Ramirez; Miki Yokokawa; Kuljeet Kaur; Daniela Ponce-Balbuena; Mohamad C Sinno; B Cicero Willis; Hamid Ghanbari; Steven R Ennis; Guadalupe Guerrero-Serna; Bettina C Henzi; Rakesh Latchamsetty; Roberto Ramos-Mondragon; Hassan Musa; Raphael P Martins; Sandeep V Pandit; Sami F Noujaim; Thomas Crawford; Krit Jongnarangsin; Frank Pelosi; Frank Bogun; Aman Chugh; Omer Berenfeld; Fred Morady; Hakan Oral; José Jalife Journal: JACC Basic Transl Sci Date: 2016-04
Authors: Alexander M Zolotarev; Brian J Hansen; Ekaterina A Ivanova; Katelynn M Helfrich; Ning Li; Paul M L Janssen; Peter J Mohler; Nahush A Mokadam; Bryan A Whitson; Maxim V Fedorov; John D Hummel; Dmitry V Dylov; Vadim V Fedorov Journal: Circ Arrhythm Electrophysiol Date: 2020-09-13
Authors: Óscar Salvador-Montañés; Rafael J Ramirez; Yoshio Takemoto; Steven R Ennis; Daniel Garcia-Iglesias; Sicong Wang; Patrick J Wolfer; Jiang Jiang; Sergey V Mironov; Sandeep V Pandit; José Jalife; Omer Berenfeld Journal: J Am Heart Assoc Date: 2021-11-02 Impact factor: 5.501
Authors: Wandi Zhu; Wei Wang; Paweorn Angsutararux; Rebecca L Mellor; Lori L Isom; Jeanne M Nerbonne; Jonathan R Silva Journal: JCI Insight Date: 2021-08-09